Biotech IPO's hit a high in 2021, but have slowed since

Year 2025 is expected to see a rebound

(Please use a modern browser to see the interactive version of this visualization)

Chart: Laura TurbaySource: Biopharma DiveGet the dataCreated with Datawrapper